Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
PAREXEL Intl Corp.

PAREXEL Intl Corp. (PRXL) Stock Overview

Explore PAREXEL Intl Corp.’s financial performance, market position, analyst ratings, and future outlook.

PRXL●NASDAQ
HealthcareMedical - Diagnostics & Research
$88.08
$0.00(0.00%)
U.S. Market opens in 59h 40m

PAREXEL Intl Corp. (PRXL)

Meyka AI Score

Z

Key Financials

Market Cap0
P/E Ratio42.35
EPS (TTM)$2.05
ROE0.17%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year TargetN/A

PRXL Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of PAREXEL Intl Corp. (NASDAQ: PRXL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, PAREXEL Intl Corp.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of PRXL on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $N/A for the NASDAQ listing.

Key metrics behind PAREXEL Intl Corp.'s NASDAQ-traded stock include a P/E ratio of 42.35 and a market capitalization of 0. Combined with our AI analysis, these give both institutional and retail investors a clear view of PRXL on the NASDAQ.

Price Performance (NASDAQ: PRXL)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
N/A
6-Month Change
N/A
Year-to-Date (YTD) Change
N/A
1-Year Change
N/A
3-Year Change
N/A
5-Year Change
N/A
All-Time (Max) Change
N/A

Contact Information

NaN
NaN
NaN, NaN, NaN, NaN

Company Facts

IPO DateNov 22, 1995
CountryNaN

Frequently Asked Questions